AUG 30, 2017 10:00 AM PDT

How Leprosy Hijacks the Immune System

WRITTEN BY: Kara Marker

The bacteria that cause leprosy manipulate the immune system to infect the body and cause nerve damage. Until now, little was known about how these bacteria work to spread disease, but with a new model organism to study them, a team of researchers is breaking down the mystery.

Modified AFB staining in a case of lepromatous leprosy showing numerous rod shaped acid fast bacilli. Department of Pathology, Calicut Medical College

From the University of Cambridge in collaboration with the University of Washington, the University of California Los Angeles, and Harvard University, scientists are now using zebrafish to study leprosy, a completely new approach to studying the condition, which some people know as “Hansen’s disease.”

Mycobacterium leprae are the painfully slow-growing microorganisms responsible for the disease that impacts the nerves, skin, eyes, and lining of the nose. It can take up to 20 years for an infected person to begin experiencing symptoms, but leprosy can be cured if detected and treated early enough. However, untreated leprosy leads to paralysis and blindness.

According to the World Health Organization (WHO), leprosy affects just 250,000 people around the world every year, a number that has decreased dramatically over the last several decades. In comparison, the WHO reports that in 1985, 5.2 million people had leprosy. The development of the drug dapsone in the 1940s was the first major breakthrough in the treatment of leprosy.

Using zebrafish, researchers wanted to find out how exactly M. laprae bacteria were infecting cells and damaging nerves. From past studies, they knew that nerve damage from leprosy, which is irreversible, is due to the destruction of the myelin sheath, which provides a protective, insulative layer over nerve fibers. Researchers believed this destruction occurred because bacteria invaded the cells responsible for producing myelin, but the recent study revealed that there more to it than that.

Researchers began with genetically modified zebrafish, altered so that their myelin fluoresces a bright green. Next they injected bacteria into nerve cells, and because youth zebrafish are transparent, what happened next was clearly visible. M. laprae infected macrophages, immune cells that typically engulf and digest pathogens. However, while M. laprae were indeed inside the macrophages, the bacteria were not destroyed.

"These 'Pac-Man'-like immune cells swallow the leprosy bacteria, but are not always able to destroy them," explained Professor Lalita Ramakrishnan. "Instead, the macrophages, which should be moving up and down the nerve fibre repairing damage, slow down and settle in place, destroying the myelin sheath."

How does macrophage-based myelin damage occur? PGL-1, a molecule employed by M. laprae, is produced to make changes in the macrophage. The result is overproduction of nitric oxide, causing damage to the cells’ mitochondria. Produced in proper amounts, nitric oxide is helpful to the immune agenda - too much and it’s toxic.

"The leprosy bacteria are, essentially, hijacking an important repair mechanism and causing it to go awry," Ramakrishnan said.

The destruction of the myelin sheath that characterizes nerve damage in leprosy is very similar to the damage that occurs in cases of multiple sclerosis. Additionally, zebrafish are used to study another disease caused by a mycobacterium, tuberculosis. "Our study appears to place leprosy in the same category of these diseases,” explained Dr. Cressida Madigan from the University of California, Los Angeles.

In light of the study’s findings, the authors maintain that early detection is still key for treating leprosy. But perhaps reversing nerve damage is possible, despite the severe damage done to the myelin sheath.

“We would like to understand how to change that,” Ramakrishnan said. “In other words, are we able to prevent damage to nerve cells in the first place, and can we additionally focus on repairing damaged nerve cells?"

The present study was published in the journal Cell.

Sources: Centers for Disease Control and Prevention, World Health Organization, University of Cambridge

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 13, 2019
Cell & Molecular Biology
JUL 13, 2019
Learning More About the Causes of Endometriosis Pain
Endometriosis can be an extremely painful disorder that significantly impacts quality of life....
AUG 11, 2019
Immunology
AUG 11, 2019
A Food Additive Could Make Your Cat Hypoallergenic
With 10-30% of the population reporting sensitivity to cat dander, you probably know someone with a cat allergy.  That's why scientists at Nestl&e...
AUG 23, 2019
Immunology
AUG 23, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Injection that Treats Peanut Allergy
Peanut allergies affect between 1 and 3% of the US population. Associated with a heightened risk of severe anaphylactic reactions, oral immunotherapy is th...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
Loading Comments...